Form 4 for TXG 10x Genomics, Inc.
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-24 · accession 0001610717-25-000398 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | 2025-11-24 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $19.00 | -13.3K | 1.02M | -1% | -$252.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-24 | S | D | 13,261 | $19.00 | 1,021,556 | D | — | — |